Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


14.08.2017

4 AJR Am J Roentgenol
1 BMJ
2 Br J Cancer
3 Breast Cancer Res
9 Breast Cancer Res Treat
1 Cancer Chemother Pharmacol
1 Cell
8 Clin Breast Cancer
1 Clin Cancer Res
1 Gene
2 Int J Cancer
1 J Clin Oncol
1 J Nucl Med
2 Lancet
1 Mod Pathol
1 N Engl J Med
2 Nat Rev Clin Oncol
1 NPJ Breast Cancer
1 Oncogene
1 Oncol Rep
5 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. HA SM, Chae EY, Cha JH, Kim HH, et al
    Association of BRCA Mutation Types, Imaging Features, and Pathologic Findings in Patients With Breast Cancer With BRCA1 and BRCA2 Mutations.
    AJR Am J Roentgenol. 2017 Aug 10:1-9. doi: 10.2214/AJR.16.16957.
    PubMed     Text format     Abstract available

  2. BERGER N, Luparia A, Di Leo G, Carbonaro LA, et al
    Diagnostic Performance of MRI Versus Galactography in Women With Pathologic Nipple Discharge: A Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2017 May 24:1-7. doi: 10.2214/AJR.16.16682.
    PubMed     Text format     Abstract available

  3. TALIAFERRO AS, Fein-Zachary V, Venkataraman S, Mehta TS, et al
    Imaging Features of Spindle Cell Breast Lesions.
    AJR Am J Roentgenol. 2017 May 24:1-11. doi: 10.2214/AJR.16.17610.
    PubMed     Text format     Abstract available

  4. ALSHAFEIY TI, Wadih A, Nicholson BT, Rochman CM, et al
    Comparison Between Digital and Synthetic 2D Mammograms in Breast Density Interpretation.
    AJR Am J Roentgenol. 2017;209:W36-W41.
    PubMed     Text format     Abstract available


    BMJ

  5. MAYOR S
    Reduced radiotherapy is as effective as whole breast treatment for early breast cancer, study finds.
    BMJ. 2017;358:j3759.
    PubMed     Text format    


    Br J Cancer

  6. SHI F, Zhang Q, Liang Z, Zhang M, et al
    One-step nucleic acid amplification assay is an accurate technique for sentinel lymph node biopsy of breast cancer patients: a meta-analysis.
    Br J Cancer. 2017 Aug 10. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available

  7. OKONJI DO, Sinha R, Phillips I, Fatz D, et al
    Comprehensive geriatric assessment in 326 older women with early breast cancer.
    Br J Cancer. 2017 Aug 10. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  8. PELEKANOU V, Carvajal-Hausdorf DE, Altan M, Wasserman B, et al
    Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance.
    Breast Cancer Res. 2017;19:91.
    PubMed     Text format     Abstract available

  9. BROWNE AJ, Kubasch ML, Gobel A, Hadji P, et al
    Concurrent antitumor and bone-protective effects of everolimus in osteotropic breast cancer.
    Breast Cancer Res. 2017;19:92.
    PubMed     Text format     Abstract available

  10. MARTIN JL, Julovi SM, Lin MZ, de Silva HC, et al
    Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade.
    Breast Cancer Res. 2017;19:90.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  11. MUSTAFA ALI M, Moeller M, Rybicki L, Moore HCF, et al
    Long-term peripheral neuropathy symptoms in breast cancer survivors.
    Breast Cancer Res Treat. 2017 Aug 8. doi: 10.1007/s10549-017-4437.
    PubMed     Text format     Abstract available

  12. WINHAM SJ, Mehner C, Heinzen EP, Broderick BT, et al
    NanoString-based breast cancer risk prediction for women with sclerosing adenosis.
    Breast Cancer Res Treat. 2017 Aug 10. doi: 10.1007/s10549-017-4441.
    PubMed     Text format     Abstract available

  13. PALMIERI C, Szydlo R, Miller M, Barker L, et al
    IPET study: an FLT-PET window study to assess the activity of the steroid sulfatase inhibitor irosustat in early breast cancer.
    Breast Cancer Res Treat. 2017 Aug 9. doi: 10.1007/s10549-017-4427.
    PubMed     Text format     Abstract available

  14. CORSINI C, Henouda S, Nejima DB, Bertet H, et al
    Early onset breast cancer: differences in risk factors, tumor phenotype, and genotype between North African and South European women.
    Breast Cancer Res Treat. 2017 Aug 5. doi: 10.1007/s10549-017-4434.
    PubMed     Text format     Abstract available

  15. SPEYER CL, Bukhsh MA, Jafry WS, Sexton RE, et al
    Riluzole synergizes with paclitaxel to inhibit cell growth and induce apoptosis in triple-negative breast cancer.
    Breast Cancer Res Treat. 2017 Aug 5. doi: 10.1007/s10549-017-4435.
    PubMed     Text format     Abstract available

  16. JOO JH, Kim SS, Ahn SD, Choi EK, et al
    Impact of pathologic diagnosis of internal mammary lymph node metastasis in clinical N2b and N3b breast cancer patients.
    Breast Cancer Res Treat. 2017 Aug 7. doi: 10.1007/s10549-017-4422.
    PubMed     Text format     Abstract available

  17. HEALEY MA, Hirko KA, Beck AH, Collins LC, et al
    Assessment of Ki67 expression for breast cancer subtype classification and prognosis in the Nurses' Health Study.
    Breast Cancer Res Treat. 2017 Aug 8. doi: 10.1007/s10549-017-4421.
    PubMed     Text format     Abstract available

  18. WISE R, Zolkiewska A
    Metalloprotease-dependent activation of EGFR modulates CD44+/CD24- populations in triple negative breast cancer cells through the MEK/ERK pathway.
    Breast Cancer Res Treat. 2017 Aug 8. doi: 10.1007/s10549-017-4440.
    PubMed     Text format     Abstract available

  19. SHIEH Y, Hu D, Ma L, Huntsman S, et al
    Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones.
    Breast Cancer Res Treat. 2017 Aug 8. doi: 10.1007/s10549-017-4430.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  20. HUANG S, Wang D, Zhang S, Huang X, et al
    Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer.
    Cancer Chemother Pharmacol. 2017 Aug 4. doi: 10.1007/s00280-017-3393.
    PubMed     Text format     Abstract available


    Cell

  21. PARMAR K, D'Andrea AD
    Aldehydes Pose a Threat to BRCA2 Mutation Carriers.
    Cell. 2017;169:979-981.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  22. ALBESHAN SM, Mackey MG, Hossain SZ, Alfuraih AA, et al
    Breast Cancer Epidemiology in Gulf Cooperation Council Countries: A Regional and International Comparison.
    Clin Breast Cancer. 2017 Jul 13. pii: S1526-8209(17)30108.
    PubMed     Text format     Abstract available

  23. CINAUSERO M, Gerratana L, De Carlo E, Iacono D, et al
    Determinants of Last-line Treatment in Metastatic Breast Cancer.
    Clin Breast Cancer. 2017 Jul 14. pii: S1526-8209(17)30270.
    PubMed     Text format     Abstract available

  24. GAITANIDIS A, Alevizakos M, Tsalikidis C, Tsaroucha A, et al
    Refusal of Cancer-Directed Surgery by Breast Cancer Patients: Risk Factors and Survival Outcomes.
    Clin Breast Cancer. 2017 Jul 18. pii: S1526-8209(17)30381.
    PubMed     Text format     Abstract available

  25. OSBORNE C, Challagalla JD, Eisenbeis CF, Holmes FA, et al
    Ixabepilone and Carboplatin for Hormone Receptor Positive/HER2-neu Negative and Triple Negative Metastatic Breast Cancer.
    Clin Breast Cancer. 2017 Jul 10. pii: S1526-8209(16)30521.
    PubMed     Text format     Abstract available

  26. MONTAGNA E, Pirola S, Maisonneuve P, De Roberto G, et al
    Lobular Metastatic Breast Cancer Patients With Gastrointestinal Involvement: Features and Outcomes.
    Clin Breast Cancer. 2017 Jul 10. pii: S1526-8209(17)30085.
    PubMed     Text format     Abstract available

  27. GERSTL B, Sullivan E, Ives A, Saunders C, et al
    Pregnancy Outcomes After a Breast Cancer Diagnosis: A Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2017 Jul 10. pii: S1526-8209(16)30537.
    PubMed     Text format     Abstract available

  28. OTSUBO R, Hirakawa H, Oikawa M, Baba M, et al
    Validation of a Novel Diagnostic Kit Using the Semidry Dot-Blot Method to Detect Metastatic Lymph Nodes in Breast Cancer: Distinguishing Macrometastases From Nonmacrometastases.
    Clin Breast Cancer. 2017 Jul 15. pii: S1526-8209(17)30274.
    PubMed     Text format     Abstract available

  29. ALTUNDAG K
    Do We Consider Locoregional Treatment of Primary Site in Patients With De Novo Stage IV Breast Cancer?: Numerous Data Are Accumulating!
    Clin Breast Cancer. 2017 Jul 20. pii: S1526-8209(17)30443.
    PubMed     Text format    


    Clin Cancer Res

  30. VAN DER VELDEN BHM, Elias SG, Bismeijer T, Loo CE, et al
    Complementary value of contralateral parenchymal enhancement on DCE-MRI to prognostic models and molecular assays in high-risk ER+HER2- breast cancer.
    Clin Cancer Res. 2017 Aug 8. pii: clincanres.0176.2017.
    PubMed     Text format     Abstract available


    Gene

  31. YI Y, Huang C, Zhang Y, Tian S, et al
    Exploring a common mechanism of alcohol-induced deregulation of RNA Pol III genes in liver and breast cells.
    Gene. 2017;626:309-318.
    PubMed     Text format     Abstract available


    Int J Cancer

  32. KVALE R, Myklebust TA, Engholm G, Heinavaara S, et al
    Prostate and breast cancer in four Nordic countries: A comparison of incidence and mortality trends across countries and age groups 1975-2013.
    Int J Cancer. 2017 Aug 10. doi: 10.1002/ijc.30924.
    PubMed     Text format     Abstract available

  33. WHITE AJ, Weinberg CR, Park YM, D'Aloisio AA, et al
    Sleep characteristics, light at night and breast cancer risk in a prospective cohort.
    Int J Cancer. 2017 Aug 9. doi: 10.1002/ijc.30920.
    PubMed     Text format     Abstract available


    J Clin Oncol

  34. CHIEN AJ, Rugo HS
    Tyrosine Kinase Inhibitors for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Is Personalizing Therapy Within Reach?
    J Clin Oncol. 2017 Aug 7:JCO2017735670. doi: 10.1200/JCO.2017.73.5670.
    PubMed     Text format    


    J Nucl Med

  35. PAQUETTE M, Lavallee E, Phoenix S, Ouellet R, et al
    Improved Estrogen Receptor Assessment by PET Using the Novel Radiotracer 4FMFES in ER+ Breast Cancer Patients: an Ongoing Phase II Clinical Trial.
    J Nucl Med. 2017 Aug 10. pii: jnumed.117.194654. doi: 10.2967/jnumed.117.194654.
    PubMed     Text format     Abstract available


    Lancet

  36. JAGSI R
    Early-stage breast cancer: falling risks and emerging options.
    Lancet. 2017 Aug 2. pii: S0140-6736(17)31599.
    PubMed     Text format    

  37. COLES CE, Griffin CL, Kirby AM, Titley J, et al
    Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.
    Lancet. 2017 Aug 2. pii: S0140-6736(17)31145.
    PubMed     Text format     Abstract available


    Mod Pathol

  38. BARTELS S, Christgen M, Luft A, Persing S, et al
    Estrogen receptor (ESR1) mutation in bone metastases from breast cancer.
    Mod Pathol. 2017 Aug 11. doi: 10.1038/modpathol.2017.
    PubMed     Text format     Abstract available


    N Engl J Med


  39. Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.
    N Engl J Med. 2017 Aug 9. doi: 10.1056/NEJMx170012.
    PubMed     Text format    


    Nat Rev Clin Oncol

  40. STANTON SE, Davidson NE
    Breast cancer: What lies beyond APHINITY for HER2-positive breast cancer?
    Nat Rev Clin Oncol. 2017 Aug 8. doi: 10.1038/nrclinonc.2017.
    PubMed     Text format    

  41. METZGER-FILHO O, Winer EP
    Breast cancer: T-DM1 - an important agent in the history of breast cancer management.
    Nat Rev Clin Oncol. 2017 Aug 8. doi: 10.1038/nrclinonc.2017.
    PubMed     Text format    


    NPJ Breast Cancer

  42. SCHROEDER B, Zhang Y, Stal O, Fornander T, et al
    Risk stratification with Breast Cancer Index for late distant recurrence in patients with clinically low-risk (T1N0) estrogen receptor-positive breast cancer.
    NPJ Breast Cancer. 2017;3:28.
    PubMed     Text format     Abstract available


    Oncogene

  43. WADA M, Canals D, Adada M, Coant N, et al
    P38 delta MAPK promotes breast cancer progression and lung metastasis by enhancing cell proliferation and cell detachment.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    Oncol Rep

  44. LIU C, Liu Z, Li X, Tang X, et al
    MicroRNA-1297 contributes to tumor growth of human breast cancer by targeting PTEN/PI3K/AKT signaling.
    Oncol Rep. 2017 Aug 7. doi: 10.3892/or.2017.5884.
    PubMed     Text format     Abstract available


    PLoS One

  45. WANG RC, Chen X, Parissenti AM, Joy AA, et al
    Sensitivity of docetaxel-resistant MCF-7 breast cancer cells to microtubule-destabilizing agents including vinca alkaloids and colchicine-site binding agents.
    PLoS One. 2017;12:e0182400.
    PubMed     Text format     Abstract available

  46. KANOMATA N, Matsuura S, Nomura T, Kurebayashi J, et al
    Correction: Preparation of a novel antiserum to aromatase with high affinity and specificity: Its clinicopathological significance on breast cancer tissue.
    PLoS One. 2017;12:e0183202.
    PubMed     Text format     Abstract available

  47. LEE S, Jiang X
    Modeling miRNA-mRNA interactions that cause phenotypic abnormality in breast cancer patients.
    PLoS One. 2017;12:e0182666.
    PubMed     Text format     Abstract available

  48. ZAGOURI F, Kotoula V, Kouvatseas G, Sotiropoulou M, et al
    Protein expression patterns of cell cycle regulators in operable breast cancer.
    PLoS One. 2017;12:e0180489.
    PubMed     Text format     Abstract available

  49. CUBASCH H, Joffe M, Ruff P, Dietz D, et al
    Breast conservation surgery versus total mastectomy among women with localized breast cancer in Soweto, South Africa.
    PLoS One. 2017;12:e0182125.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  50. CHANG YS, Jalgaonkar SP, Middleton JD, Hai T, et al
    Stress-inducible gene Atf3 in the noncancer host cells contributes to chemotherapy-exacerbated breast cancer metastasis.
    Proc Natl Acad Sci U S A. 2017 Aug 7. pii: 201700455.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: